The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure
Open accessAbstract
Background— To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure (DHF), left ventricular (LV) myocardial structure and function were compared in LV endomyocardial biopsy samples of patients with systolic and diastolic heart failure. Methods and Results— Patients hospitalized for worsening heart failure were classified as having SHF (n=22; LV ejection fraction (EF) 34±2%) or DHF (n=22; LVEF 62±2%). No patient had coronary artery disease or biopsy evidence of infiltrative or inflammatory myocardial disease. More DHF patients had a history of arterial hypertension and were obese. Biopsy samples were analyzed with histomorphometry and electron microscopy. Single cardiomyocytes were isolated from the samples, stretched to a sarcomere length of 2.2 μm to measure passive force (F passive ), and activated with calcium-containing solutions to measure total force. Cardiomyocyte diameter was higher in DHF (20.3±0.6 versus 15.1±0.4 μm, P <0.001), but collagen volume fraction was equally elevated. Myofibrillar density was lower in SHF (36±2% versus 46±2%, P <0.001). Cardiomyocytes of DHF patients had higher F passive (7.1±0.6 versus 5.3±0.3 kN/m 2 ; P <0.01), but their total force was comparable. After administration of protein kinase A to the cardiomyocytes, the drop in F passive was larger ( P <0.01) in DHF than in SHF. Conclusions— LV myocardial structure and function differ in SHF and DHF because of distinct cardiomyocyte abnormalities. These findings support the clinical separation of heart failure patients into SHF and DHF phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,563
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,184
Kawaguchi, M., Hay, I., Fetics, B., & Kass, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000048123.22359.a0 · Cited by 934
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Defining Diastolic Heart Failure: A Call for Standardized Diagnostic Criteria
Vasan, R. S., & Levy, D. (2000) · Circulation · doi:10.1161/01.cir.101.17.2118 · Cited by 729
How to diagnose diastolic heart failure
Paulus, W. J., Brutsaert, D. L., Gillebert, T. C., Rademakers, F., Stanislas, U., Leite-Moreira, A. F., Om, H., Zh, J., Kaufmann, P. A., Mandinov, L., et al. (1998) · Ghent University Academic Bibliography (Ghent University) · Cited by 649
Self-citation
Cited by
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
“A comparative analysis of endomyocardial biopsy samples from HFPEF and HFREF (3,27) indeed showed the presence of replacement fi brosis in HFREF but not in HFPEF.”
InfluentialSelf-citationPaulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P., Smiseth, O. A., De Keulenaer, G., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,679
Self-citationHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Self-citationPhysiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
“HFpEF patients with EF 50% at diagnosis tended to have less severe CAD at autopsy (CAD total score 12 (7-14)) than HFpEF patients with EF 40-49% at HF diagnosis (12.”
BackgroundBraunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
The pathophysiology of heart failure with preserved ejection fraction
Borlaug, B. A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.83 · Cited by 726
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Self-citationHeart Failure With Preserved Ejection Fraction
Borlaug, B. A., Sharma, K., Shah, S. J., & Ho, J. E. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.049 · Cited by 742
Zile, M. R., Baicu, C. F., S. Ikonomidis, J., Stroud, R. E., Nietert, P. J., Bradshaw, A. D., Slater, R., Palmer, B. M., Van Buren, P., Meyer, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013215 · Cited by 681
Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.931451 · Cited by 644
Franssen, C., Chen, S., Unger, A., Korkmaz, H. I., De Keulenaer, G. W., Tschöpe, C., Leite-Moreira, A. F., Musters, R., Niessen, H. W. M., Linke, W. A., et al. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.007 · Cited by 597
Self-citationKasner, M., Westermann, D., Steendijk, P., Gaub, R., Wilkenshoff, U., Weitmann, K., Hoffmann, W., Poller, W., Schultheiss, H.-P., Pauschinger, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.661983 · Cited by 565
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Seferović, P. M., & Paulus, W. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv134 · Cited by 552
Self-citationLam, C. S. P., Roger, V. L., Rodeheffer, R. J., Bursi, F., Borlaug, B. A., Ommen, S. R., Kass, D. A., & Redfield, M. M. (2007) · Circulation · doi:10.1161/circulationaha.106.659763 · Cited by 550
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão-Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 525
Self-citationZile, M. R., Gottdiener, J. S., Hetzel, S. J., McMurray, J. J., Komajda, M., McKelvie, R., Baicu, C. F., Massie, B. M., & Carson, P. E. (2011) · Circulation · doi:10.1161/circulationaha.110.011031 · Cited by 517
Heart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies
Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Borlaug, B. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.110.954388 · Cited by 456
Shah, S. J., Borlaug, B. A., Kitzman, D. W., McCulloch, A. D., Blaxall, B. C., Agarwal, R., Chirinos, J. A., Collins, S., Deo, R. C., Gladwin, M. T., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041886 · Cited by 436
Pathophysiology of heart failure
Schwinger, R. H. G. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-302 · Cited by 428
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Mishra, S., & Kass, D. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00480-6 · Cited by 417
Krüger, M., Kötter, S., Grützner, A., Lang, P., Andresen, C., Redfield, M. M., Butt, E., dos Remedios, C. G., & Linke, W. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.184408 · Cited by 407
Self-citationPaulus, W. J., & Zile, M. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318159 · Cited by 393
Self-citationSimmonds, S. J., Cuijpers, I., Heymans, S., & Jones, E. A. V. (2020) · Cells · doi:10.3390/cells9010242 · Cited by 381
Borbély, A., Falcao-Pires, I., van Heerebeek, L., Hamdani, N., Édes, I., Gavina, C., Leite-Moreira, A. F., Bronzwaer, J. G. F., Papp, Z., van der Velden, J., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.193326 · Cited by 364
Self-citationDiffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
Senni, M., Paulus, W. J., Gavazzi, A., Fraser, A. G., Diez, J., Solomon, S. D., Smiseth, O. A., Guazzi, M., Lam, C. S. P., Maggioni, A. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu204 · Cited by 355
Self-citationUnlocking the Mysteries of Diastolic Function
Lester, S. J., Tajik, A. J., Nishimura, R. A., Oh, J. K., Khandheria, B. K., & Seward, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.061 · Cited by 350
Inflammatory Cytokines in Heart Failure: Mediators and Markers
Gullestad, L., Ueland, T., Vinge, L. E., Finsen, A., Yndestad, A., & Aukrust, P. (2012) · Cardiology · doi:10.1159/000338166 · Cited by 350
Zile, M. R., Gaasch, W. H., Anand, I. S., Haass, M., Little, W. C., Miller, A. B., Lopez-Sendon, J., Teerlink, J. R., White, M., McMurray, J. J., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909614 · Cited by 335
Effects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction
Schwartzenberg, S., Redfield, M. M., From, A. M., Sorajja, P., Nishimura, R. A., & Borlaug, B. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.062 · Cited by 331
Gigantic Business: Titin Properties and Function Through Thick and Thin
Linke, W. A., & Hamdani, N. (2014) · Circulation Research · doi:10.1161/circresaha.114.301286 · Cited by 330
Self-citationKasner, M., Westermann, D., Lopez, B., Gaub, R., Escher, F., Kühl, U., Schultheiss, H.-P., & Tschöpe, C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.024 · Cited by 328
Pre-Clinical Diastolic Dysfunction
Wan, S.-H., Vogel, M. W., & Chen, H. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.063 · Cited by 327
Developing Therapies for Heart Failure With Preserved Ejection Fraction
Butler, J., Fonarow, G. C., Zile, M. R., Lam, C. S., Roessig, L., Schelbert, E. B., Shah, S. J., Ahmed, A., Bonow, R. O., Cleland, J. G. F., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.10.006 · Cited by 324
Coronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 321
Ventricular–Vascular Interaction in Heart Failure
Borlaug, B. A., & Kass, D. A. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.10.001 · Cited by 315
Lam, C. S. P., Lyass, A., Kraigher-Krainer, E., Massaro, J. M., Lee, D. S., Ho, J. E., Levy, D., Redfield, M. M., Pieske, B. M., Benjamin, E. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.979203 · Cited by 314
Hamdani, N., Franssen, C., Lourenço, A., Falcão-Pires, I., Fontoura, D., Leite, S., Plettig, L., López, B., Ottenheijm, C. A., Becher, P. M., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000539 · Cited by 307
Self-citationHahn, V. S., Yanek, L. R., Vaishnav, J., Ying, W., Vaidya, D., Lee, Y. Z. J., Riley, S. J., Subramanya, V., Brown, E. E., Hopkins, C. D., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2020.04.007 · Cited by 306
Linke, W. A. (2008) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.029 · Cited by 305
Self-citationHasenfuß, G., Hayward, C., Burkhoff, D., Silvestry, F. E., McKenzie, S., Gustafsson, F., Malek, F., Van der Heyden, J., Lang, I., Petrie, M. C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00704-2 · Cited by 294
Heart Failure With Normal Left Ventricular Ejection Fraction
Maeder, M. T., & Kaye, D. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.007 · Cited by 270
Cardiac Titin: A Multifunctional Giant
LeWinter, M. M., & Granzier, H. (2010) · Circulation · doi:10.1161/circulationaha.109.860171 · Cited by 264
Immune Mechanisms in Heart Failure
Zhang, Y., Bauersachs, J., & Langer, H. F. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.942 · Cited by 262
Vascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196
Passive Stiffness of Myocardium From Congenital Heart Disease and Implications for Diastole
Chaturvedi, R. R., Herron, T., Simmons, R., Shore, D., Kumar, P., Sethia, B., Chua, F., Vassiliadis, E., & Kentish, J. C. (2010) · Circulation · doi:10.1161/circulationaha.109.850677 · Cited by 167
Kooij, V., Saes, M., Jaquet, K., Zaremba, R., Foster, D. B., Murphy, A. M., dos Remedios, C., van der Velden, J., & Stienen, G. J. M. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.002 · Cited by 73
Self-citationDiabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction
Lam, C. S. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115579006 · Cited by 69
Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction
Tanaka, K., Valero-Muñoz, M., Wilson, R. M., Essick, E. E., Fowler, C. T., Nakamura, K., van den Hoff, M., Ouchi, N., & Sam, F. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.04.002 · Cited by 59
“Myocardial biopsies obtained from a highly selected, younger patient population with HFpEF demonstrated cardiac myocyte hypertrophy, interstitial fibrosis, and evidence of systemic and myocardial inflammation, and oxidative stress (5,6).”
Background
Metadata
- Authors
- van Heerebeek, L., Borbély, A., Niessen, H. W. M., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Linke, W. A., Laarman, G. J., & Paulus, W. J.
- Venue
- Circulation
- Published
- 2006-04-25
- Volume
- 113
- Issue
- 16
- Pages
- 1966-1973
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2106909429
- Cited by
- 664
- References
- 44
- FWCI
- 28.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.